Outcomes after shifting Bevacizumab to Ranibizumab in patients with wet age–related macular degeneration
碩士 === 中山醫學大學 === 醫學研究所 === 103 === Objective：The objective of this study is to compare visual acuity and central retinal thickness in patients initially treated with bevacizumab (Avastin) and switched to ranibizumab (Lucentis) for neovascular age-related macular degeneration (AMD). Methods and Mate...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2015
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/24690880312960017678 |